BioMarin Pharma (BMRN) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $54.69 -0.6%
Revenue Growth %: +13.2%
Financial Fact:
INCOME FROM OPERATIONS: -60.09M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +13.2%
Financial Fact:
INCOME FROM OPERATIONS: -60.09M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q4 EPS of ($0.47), $0.12 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $230.9 million versus the consensus estimate of $189.01 million.
BioMarin Pharma sees FY2015 revenue of $885-915 million, versus the consensus of $880.6 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
- Wall Street scrambles to lift Micron price targets ahead of earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
